Products > PERFADEX®


addmedica Home Page
News
addmedica
Chairman's foreword
Team
Unmet medical needs and products
Job offers
Business opportunities
European network
Business development
Products
SIKLOS® (Hydroxycarbamide)
PERFADEX®
LUMIDERM® 6000
HYALOMATRIX® PA
Login application form
Comments and questions?
Favorite links
Search
A memorial to Jean-Michel

Références

HomeLiens favorisContact-usWebsite map
Présentation | Brochures et Notices d'utilisation | Gamme Perfadex | Références | Questions et réponses | Comment commander?

Principales publications

1.De Perrot M, Liu M, Waddell TK, and Keshavjee S. Ischemia–Reperfusion–induced Lung Injury – State of the art. Am J Respir Crit Care Med 2003; 167 :490–511

To abstract
 
2. Frost-Arner L, Bergqvist D. Effect of isovolemic hemodilution with dextran and albumin on thrombus formation in artificial vessel grafts inserted into the abdominal aorta of the rabbit. Microsurgery 1995; 16:357-61.

To abstract

3. Müller C, Fürst H, Reichenspurner H, Briegel J, Groh J, Reichart B. and the Munich Lung Transplant Group. Lung procurement by low-potassium dextran and the effect on preservation injury.  Transplantation. 1999; 68:1139-43.

To abstract

4. Strüber M, Wilhelmi M, Harringer W. et al. Flush perfusion with low potassium dextran solution improves early graft function in clinical lung transplantation. Eur J Cardiothorac Surg 2001; 19:190-4.

To abstract

5. Fischer S, Matte-Martyn A, De Perrot M. et al. Low-potassium dextran preservation solution improves lung function after human lung transplantation. J Thorac Cardiovasc Surg 2001; 121:594-6.
 
6. Rega F, et al and the Leuven Lung Transplant Group. Switch from Euro-Collins® to Perfadex® for pulmonary graft preservation resulted in superior outcome in transplant recipients. J Heart Lung Transplant 2003; 22:S111

7. Sakamaki F, et al. Reduced lipid peroxidation and ischemia-reperfusion injury after lung transplantation using low-potassium dextran solution for lung preservation.  Am J Respir Crit Care Med 1997; 156:1073-81.

To abstract

8. Wittwer T, Franke UF, Fehrenbach A, Ochs M, Sandhaus T, Schuette A, Richter S, Dreyer N, Knudsen L, Müller T, Schubert H, Richter J, Wahlers T. Experimental lung transplantation: impact of preservation solution and route of delivery. J Heart Lung Transplant 2005; 24:1081-90.

To abstract

9. Steen S, Kimblad PO, Sjöberg T, Lindberg L, Ingemansson R, Massa G. Safe lung preservation for twenty-four hours with Perfadex®.  Ann Thorac Surg 1994; 57:450-7.

To abstract

10. Steen S. Preservation of the Endothelium in Cardiovascular surgery - Some Practical Suggestions - A review.  Scand Cardiovasc J 2001; 35:297-301.

11. Kelly RF. Current strategies in lung preservation J Lab Clin Med 2000; 136:427-40

To abstract

12. Van Raemdonck D, Steen S. Lung preservation. Eur Resp J 2003; 8:86-97

To article

13. Ingemansson R, Massa G, Pandita RK, Sjöberg T, Steen S. Perfadex® is superior to Euro-Collins® solution regarding 24-hour preservation of vascular function. Ann Thorac Surg 1995; 60:1210-14.

To abstract

14. Keshavjee SH, Yamazaki F, Yokomise H. et al. The role of dextran 40 and potassium in extended hypothermic lung preservation for transplantation. J Thorac Cardiovasc Surg 1992; 103:314-25.

To abstract

15. King R C, et al. Acellular low-potassium dextran preserves pulmonary function after 48 hours of ischemia. Ann Thorac Surg, 1997; 64:795-800.

To abstract

16. Strüber M, et al. Low-potassium dextran solution ameliorates reperfusion injury of the lung and protects surfactant function. . J Thorac Cardiovasc Surg 2000; 120:566-72.


17. Ingemansson, R et al. Importance of calcium in long-term preservation of the vasculature. Ann Thorac Surg 1996; 61:1158-62.





© ADDMEDICA - adding value for health
Legal Information